Research Article
Evaluation of 12-Lipoxygenase (12-LOX) and Plasminogen Activator Inhibitor 1 (PAI-1) as Prognostic Markers in Prostate Cancer
Table 1
Characteristics of the study group.
| | | BPH
Mean ± SD
(median) | Prostate cancer
Mean ± SD
(median) | |
| | Age of patients (years) |
(65) |
(72) | 0.02 | | Volume of prostate (mL) |
(55.7) |
(47.7) | 0.01 | | Volume of adenoma (mL) |
(25.1) |
(18.3) | 0.004 | | Volume of cancer foci (mL) | — |
(0.2) | | | PSA (ng/mL) |
(5.0) |
(8.6) | 0.0004 | | Gleason grade ≤ 6 | — | 63% | | | Gleason grade > 6 | — | 37% | |
|
|
